Company: INDP
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001641172-25-005234
Chunk: 44

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 44
---
 authority to grant equity awards to certain employees, as further described in its charter and subject to the terms of our equity plans.

The members of our Compensation Committee are Mr. Maddaluna and Mr. Hayes. Mr. Maddaluna serves as the Chairperson of the Compensation Committee. Each member of the Compensation Committee qualifies as an independent director under Nasdaq’s heightened independence standards for members of a compensation committee and as a “non-employee director” as defined in Rule 16b-3 of the Exchange Act.

The Compensation Committee met two times in 2024.

| 26 |

Nominating Committee

Our Nominating Committee’s responsibilities include:

| ● | identifying                                                                                                                           
 individuals qualified to become Board members;                                                                                        |
| ● | recommending                                                                                                                          
 to the Board the persons to be nominated for election as directors and to each Board committee;                                       |
| ● | reviewing                                                                                                                             
 with the Chief Executive Officer and making recommendations to the Board with respect to our succession plans for the Chief Executive 
 Officer and other executive officers;                                                                                                 |
| ● | reviewing                                                                                                                             
 and making recommendations to the Board the composition and chairperson of each Board committee; and                                  |
| ● | overseeing                                                                                                                            
 the evaluation of the Board and its committees.                                                                                       |

The Nominating Committee charter is available on the Investors page of our website at www.indaptusrx.com. The members of our Nominating Committee are Ms. Karah and Mr. Maddaluna. Ms. Karah serves as the Chairperson of the Nominating Committee. The Nominating Committee has the authority to consult with outside advisors or retain search firms to assist in the search for qualified candidates or consider director candidates recommended by our stockholders.

The Nominating Committee did not have any meetings in 2024.

Science and Technology Committee

Our Science and Technology Committee’s responsibilities include:

| ● | reviewing                                                                                                                               
 and advising on our drug development strategy, including the selection of therapeutic targets, the design and execution of clinical     
 trials, and the regulatory pathway for approval;                                                                                        |
| ● | assessing                                                                                                                               
 our research pipeline and recommending changes or improvements to ensure a sustainable and diverse portfolio of drug candidates;        |
| ● | evaluating                                                                                                                              
 our intellectual property strategy and overseeing the implementation of appropriate measures to protect our discoveries and inventions; 
 and                                                                                                                                     |
| ● | reviewing                                                                                                                               
 our manufacturing strategy and overseeing the quality controls put in place to meet regulatory requirements.                            |

The members of